Probabilistically safe controllers based on control barrier functions and scenario model predictive control by Do Nascimento, A, Papachristodoulou, A, Margellos, K

Evaluation Of HHIP Polymorphisms And Their Relationship With Chronic Obstructive Pulmonary Disease Phenotypes by Bártholo TP, Porto LC, Pozzan R, Nascimento A, Da Costa CH

Get full text

Structural insights into functional overlapping and differentiation among myosin V motors by Nascimento, A, Trindade, D, Tonoli, C, De Giuseppe, P, Assis, L, Honorato, R, Deoliveira, P, Mahajan, P, Burgess-Brown, N, von Delft, F, Larson, R, Murakami, M

Structural insights into functional overlapping and differentiation among myosin V motors. by Nascimento, A, Trindade, D, Tonoli, C, de Giuseppe, P, Assis, L, Honorato, R, de Oliveira, P, Mahajan, P, Burgess-Brown, N, von Delft, F, Larson, R, Murakami, M

Hexosamine biosynthetic pathway mutations cause neuromuscular transmission defect. by Senderek, J, Müller, J, Dusl, M, Strom, T, Guergueltcheva, V, Diepolder, I, Laval, S, Maxwell, S, Cossins, J, Krause, S, Muelas, N, Vilchez, J, Colomer, J, Mallebrera, C, Nascimento, A, Nafissi, S, Kariminejad, A, Nilipour, Y, Bozorgmehr, B, Najmabadi, H, Rodolico, C, Sieb, J, Steinlein, O, Schlotter, B, Schoser, B

Congenital myasthenic syndrome with tubular aggregates caused by GFPT1 mutations. by Guergueltcheva, V, Müller, J, Dusl, M, Senderek, J, Oldfors, A, Lindbergh, C, Maxwell, S, Colomer, J, Mallebrera, C, Nascimento, A, Vilchez, J, Muelas, N, Kirschner, J, Nafissi, S, Kariminejad, A, Nilipour, Y, Bozorgmehr, B, Najmabadi, H, Rodolico, C, Sieb, J, Schlotter, B, Schoser, B, Herrmann, R, Voit, T, Steinlein, O

Congenital myasthenic syndrome with tubular aggregates caused by GFPT1 mutations by Guergueltcheva, V, Müller, J, Dusl, M, Senderek, J, Oldfors, A, Lindbergh, C, Maxwell, S, Colomer, J, Mallebrera, C, Nascimento, A, Vilchez, J, Muelas, N, Kirschner, J, Nafissi, S, Kariminejad, A, Nilipour, Y, Bozorgmehr, B, Najmabadi, H, Rodolico, C, Sieb, J, Schlotter, B, Schoser, B, Herrmann, R, Voit, T, Steinlein, O

Evidentiary basis of the first regulatory qualification of a digital primary efficacy endpoint by Servais, L, Strijbos, P, Poleur, M, Mirea, A, Butoianu, N, Sansone, VA, Vuillerot, C, Schara-Schmidt, U, Scoto, M, Seferian, AM, Previtali, SC, Tulinius, M, Nascimento, A, Furlong, P, Singh, T, Dreghici, RD, Goemans, N, Mercuri, E, Straub, V, Ormazabal, MG, Braid, J, Muntoni, F, Tricot, A, Annoussamy, M

OXA1L mutations cause mitochondrial encephalopathy and a combined oxidative phosphorylation defect by Thompson, K, Mai, N, Oláhová, M, Scialó, F, Formosa, LE, Stroud, DA, Garrett, M, Lax, NZ, Robertson, FM, Jou, C, Nascimento, A, Ortez, C, Jimenez‐Mallebrera, C, Hardy, SA, He, L, Brown, GK, Marttinen, P, McFarland, R, Sanz, A, Battersby, BJ, Bonnen, PE, Ryan, MT, Chrzanowska‐Lightowlers, ZM, Lightowlers, RN

Retrospective natural history of thymidine kinase 2 deficiency by Garone, C, Taylor, R, Nascimento, A, Poulton, J, Fratter, C, Domínguez-González, C, Evans, J, Loos, M, Isohanni, P, Suomalainen, A, Ram, D, Hughes, M, McFarland, R, Barca, E, Lopez Gomez, C, Jayawant, S, Thomas, N, Manzur, A, Kleinsteuber, K, Martin, M, Kerr, T, Gorman, G, Sommerville, E, Chinnery, P, Hofer, M, Karch, C, Ralph, J, Cámara, Y, Madruga-Garrido, M, Domínguez-Carral, J, Ortez, C, Emperador, S, Montoya, J, Chakrapani, A, Kriger, J, Schoenaker, R, Levin, B, Thompson, J, Long, Y, Rahman, S, Donati, M, DiMauro, S, Hirano, M